Table 2.

Associations of CCR5-▵32 and CCR2-64I With NHL and Other AIDS Indicator Conditions in HIV-1–Infected Patients

No. of CCR5 +/+ No. of CCR5 +/Δ32 or Δ32/Δ32Odds Ratio 95% CI No. of CCR2 +/+*No. of CCR2 +/64I or 64I/64I*Odds Ratio 95% CI
NHL 49  2  0.2  (0.0-0.9)  22  7  1.3  (0.4-3.1) 
Kaposi’s sarcoma 23  3  0.7  (0.1-2.9)  22  0.5  (0.1-2.1)  
Opportunistic infection 235  37 1.0  (0.6-1.6)  179  31  0.6  (0.3-0.9)  
No AIDS indicator clinical conditions  345  58  1.2  (0.7-1.8) 259  82  1.7  (1.1-2.7) 
No. of CCR5 +/+ No. of CCR5 +/Δ32 or Δ32/Δ32Odds Ratio 95% CI No. of CCR2 +/+*No. of CCR2 +/64I or 64I/64I*Odds Ratio 95% CI
NHL 49  2  0.2  (0.0-0.9)  22  7  1.3  (0.4-3.1) 
Kaposi’s sarcoma 23  3  0.7  (0.1-2.9)  22  0.5  (0.1-2.1)  
Opportunistic infection 235  37 1.0  (0.6-1.6)  179  31  0.6  (0.3-0.9)  
No AIDS indicator clinical conditions  345  58  1.2  (0.7-1.8) 259  82  1.7  (1.1-2.7) 
*

Not analyzed on pediatric cohort.

In male homosexuals only.

Includes all AIDS-defining clinical conditions except for NHL and Kaposi’s sarcoma.

Close Modal

or Create an Account

Close Modal
Close Modal